These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design. Marinelli L, Lavecchia A, Gottschalk KE, Novellino E, Kessler H. J Med Chem; 2003 Oct 09; 46(21):4393-404. PubMed ID: 14521404 [Abstract] [Full Text] [Related]
3. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes. Kumar SP, Jha PC. Comb Chem High Throughput Screen; 2018 Oct 09; 21(1):26-40. PubMed ID: 29295689 [Abstract] [Full Text] [Related]
5. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study. Xiang M, Lin Y, He G, Chen L, Yang M, Yang S, Mo Y. J Mol Model; 2012 Nov 09; 18(11):4917-27. PubMed ID: 22736220 [Abstract] [Full Text] [Related]
12. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T, Zhu L, Chen L, Xu X. J Chem Inf Comput Sci; 2003 Nov 09; 43(1):273-87. PubMed ID: 12546563 [Abstract] [Full Text] [Related]
13. [Pharmacophore model of integrin alphavbeta3 antagonists]. Cheng GY, Ni GH, Jiang FC. Yao Xue Xue Bao; 2009 Apr 09; 44(4):379-85. PubMed ID: 19545055 [Abstract] [Full Text] [Related]
15. Fully automated flexible docking of ligands into flexible synthetic receptors using forward and inverse docking strategies. Kämper A, Apostolakis J, Rarey M, Marian CM, Lengauer T. J Chem Inf Model; 2006 Apr 09; 46(2):903-11. PubMed ID: 16563022 [Abstract] [Full Text] [Related]
16. Multiple N-methylation by a designed approach enhances receptor selectivity. Chatterjee J, Ovadia O, Zahn G, Marinelli L, Hoffman A, Gilon C, Kessler H. J Med Chem; 2007 Nov 29; 50(24):5878-81. PubMed ID: 17973471 [Abstract] [Full Text] [Related]